Robert L. Ruxer
Robert L. Ruxer publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms and Colorectal Cancer Treatments and Studies.
- World rank
- #3,652,095 of 7,710,434 ranked researchers
- Rank in United States
- #1,013,718 of 1,627,098
- Works
- 19
- Citations
- 1.1k
- Citations per work
- 58.3
What does Robert L. Ruxer research?
Robert L. Ruxer's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1263.0%
- Medicine1263.0%
- Life Sciences418.6%
- Everything else318.4%
- 1Oncology30% of their works
- 2Pulmonary and Respiratory Medicine24% of their works
- 3Molecular Biology17% of their works
- 4Surgery6% of their works
- 5Gastroenterology4% of their works
- 6Endocrinology2% of their works
Research topics
Which keywords describe Robert L. Ruxer's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, Prognostic Factors, ALK Inhibitors, EGFR Mutations, Cetuximab and DNA.
- Taxanes
- Imatinib Mesylate
- HDAC Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- Topoisomerases
- KRAS Mutations
- DNA
- EGFR Mutations
- Prognostic Factors
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- ALK Inhibitors
- Cetuximab
- Genomic Profiles
- Small-Cell Lung Cancer
- Antimicrobial Agents
- Febrile Neutropenia
- Histone Deacetylases
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy144 topics
- Clinical Trials92 topics
- Targeted Therapy92 topics
- Prognostic Factors62 topics
- ALK Inhibitors51 topic
- EGFR Mutations51 topic
- Cetuximab41 topic
- DNA41 topic
- Genomic Profiles41 topic
- KRAS Mutations41 topic
- Small-Cell Lung Cancer41 topic
- Topoisomerases41 topic
- Antimicrobial Agents21 topic
- Chemotherapy-Induced Peripheral Neuropathy21 topic
- Febrile Neutropenia21 topic
- HDAC Inhibitors21 topic
- Histone Deacetylases21 topic
- Imatinib Mesylate21 topic
- Sunitinib21 topic
- Taxanes21 topic
Where does Robert L. Ruxer work?
Robert L. Ruxer's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Robert L. Ruxer have?
OpenAlex counts 19 works and 1,107 citations for Robert L. Ruxer, an h-index of 12, ranking #3,652,095 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert L. Ruxer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.